Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC

Clinical trial NCT07603661 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07603661
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2026-06-01
Primary completion: 2028-06-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.